TBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TrueBlue Inc (TBI) is not a strong buy for a beginner, long-term investor at this moment. While insiders are buying heavily, the technical indicators are bearish, and the stock lacks strong upward momentum. Additionally, the financial performance, though improving, still shows a negative net income and EPS. With no significant news catalysts or strong trading signals, it is better to hold off on investing in TBI right now.
The technical indicators for TBI show a bearish trend. The MACD is below zero and negatively contracting, RSI is neutral at 38.998, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Key support levels are at 3.502 and 3.298, with resistance at 4.163 and 4.367. Overall, the stock is trading below its pivot point of 3.833, indicating a weak price trend.
Insiders are buying heavily, with a 1035.89% increase in buying activity over the last month. Revenue and net income have shown significant YoY improvement in the latest quarter.
Gross margin has dropped significantly YoY, and the stock has a 70% chance of minimal price movement in the next week and month.
In Q4 2025, revenue increased by 8.35% YoY to $418.18M, and net income improved by 169.42% YoY but remains negative at -$31.54M. EPS also improved by 162.50% YoY but is still negative at -1.05. Gross margin dropped by 19.79% YoY to 20.06%.
Baird lowered the price target from $7 to $5.50 while maintaining an Outperform rating. This reflects a cautious but slightly optimistic stance on the stock.
